<bill session="118" type="s" number="125" updated="2024-07-24T15:24:01Z">
  <state datetime="2023-01-26">REFERRED</state>
  <status>
    <introduced datetime="2023-01-26"/>
  </status>
  <introduced datetime="2023-01-26"/>
  <titles>
    <title type="display">China Trade Relations Act of 2023</title>
    <title type="short" as="introduced">China Trade Relations Act of 2023</title>
    <title type="official" as="introduced">A bill to withdraw normal trade relations treatment from, and apply certain provisions of title IV of the Trade Act of 1974 to, products of the People's Republic of China, and to expand the eligibility requirements for products of the People's Republic of China to receive normal trade relations treatment in the future, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="C001095"/>
  <cosponsors>
    <cosponsor bioguide_id="B001305" joined="2023-01-26"/>
    <cosponsor bioguide_id="S001217" joined="2023-01-26"/>
    <cosponsor bioguide_id="V000137" joined="2023-01-26"/>
  </cosponsors>
  <actions>
    <action datetime="2023-01-26">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-01-26" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="118" type="h" number="638" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Foreign trade and international finance"/>
    <term name="Asia"/>
    <term name="China"/>
    <term name="Congressional oversight"/>
    <term name="Congressional-executive branch relations"/>
    <term name="Human rights"/>
    <term name="Legislative rules and procedure"/>
    <term name="Normal trade relations, most-favored-nation treatment"/>
    <term name="Presidents and presidential powers, Vice Presidents"/>
    <term name="Sanctions"/>
    <term name="Trade restrictions"/>
    <term name="U.S. and foreign investments"/>
  </subjects>
  <amendments/>
  <summary date="2023-02-17T19:57:58Z" status="Introduced in Senate">China Trade Relations Act of 2023

This bill withdraws normal trade relations treatment from China and expands the bases of ineligibility for this treatment to include specified violations of human rights by China.

Specifically, during any period in which China engages in specified activities (e.g., using slave labor, performing forced abortion or sterilization, or hindering the free exercise of religion) (1) products from China shall not be eligible to receive nondiscriminatory treatment (normal trade relations), (2) China may not participate in any U.S. program that extends credits or credit guarantees or investment guarantees, and (3) the President may not conclude any commercial agreement with China.</summary>
</bill>
